Quantcast

Latest VentiRx Pharmaceuticals Inc. Stories

2011-03-21 11:45:00

SAN FRANCISCO, March 21, 2011 /PRNewswire/ -- VentiRx Pharmaceuticals, Inc., a biopharmaceutical company focused on the development of novel Toll-Like Receptor 8 (TLR8) agonists and antagonists for the treatment of cancer, respiratory and autoimmune diseases, announced today the presentation of positive clinical results from its randomized, placebo-controlled clinical trial evaluating VTX-1463 for the treatment of allergic rhinitis.

2009-04-16 06:00:00

First Selective TLR8 Agonist to Advance for Treatment of Allergy SAN DIEGO, April 16 /PRNewswire/ -- VentiRx Pharmaceuticals, Inc., a biopharmaceutical company focused on the development of novel Toll-Like Receptor 8 (TLR8) agonists for the treatment of cancer, respiratory and inflammatory diseases, announced today that it has initiated a Phase I clinical trial of VTX-1463, a selective intranasal TLR8 agonist for the treatment of allergic rhinitis.

2008-12-04 05:00:00

First Selective TLR8 Agonist to Advance to Clinical Trials SAN DIEGO, Dec.


Word of the Day
mitraille
  • Small missiles, especially grape, canister, fragments of iron, and the like, when fired, as upon an enemy at close quarters.
  • To fire mitraille at.
The word 'mitraille' comes from the Old French 'mitaille', meaning 'small coins', sometimes used to mean 'scrap iron'.